Learn More
Invitrogen™ LanthaScreen™ Tb-p4E-BP1 (pThr46) Antibody Kit
A part of the PI3K/AKT Pathway, 4E-BP1 (EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1) is a cytosolic protein that is phosphorylated at Thr46 by mTORC1 upon stimulation of the pathway.
Brand: Invitrogen™ PV4757
Description
A part of the PI3K/AKT Pathway, 4E-BP1 (EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1) is a cytosolic protein that is phosphorylated at Thr46 by mTORC1 upon stimulation of the pathway.
For use in combination with the GFP-4E-BP1 physiological protein substrate (Cat. No. PV4759) to evaluate inhibitors in medium to high throughput screening applications. An optimized mTor assay buffer (PV4794) is also available.
Specifications
Serine/threonine kinase | |
0.52mg/mL | |
150kDa | |
RUO | |
Primary | |
Terbium-labeled anti-4E-BP1 [pThr46] antibody in HEPES buffered saline. Store at -20°C. |
|
Biochemical terbium phospho-specific activity | |
340/490, 520 nm | |
Dry Ice | |
Hu | |
Serine/Threonine Kinases | |
FRAP1 (mTOR), FRAP1 (mTOR) |
Kinase Assay, Enzyme and Protein Activity Assays, Kinase Assay | |
Tb (Terbium)/GFP (EmGFP) | |
25 μg | |
Target and Lead Identification and Validation | |
1 Kit(s) | |
150,000 Da | |
384-well Plate | |
Human | |
End Point | |
mTOR, FRAP1 | |
TR-FRET | |
LanthaScreen™ |
For Research Use Only. Not for use in diagnostic procedures.